Seer Inc (SEER)
1.75
-0.02
(-1.13%)
USD |
NASDAQ |
Apr 25, 16:00
1.755
0.00 (0.00%)
Pre-Market: 20:00
Seer Total Assets (Quarterly): 436.27M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 436.27M |
| September 30, 2023 | 444.85M |
| June 30, 2023 | 461.20M |
| March 31, 2023 | 472.79M |
| December 31, 2022 | 487.93M |
| September 30, 2022 | 500.21M |
| June 30, 2022 | 516.30M |
| March 31, 2022 | 527.08M |
| Date | Value |
|---|---|
| December 31, 2021 | 539.14M |
| September 30, 2021 | 527.84M |
| June 30, 2021 | 537.05M |
| March 31, 2021 | 545.64M |
| December 31, 2020 | 442.32M |
| September 30, 2020 | 133.89M |
| December 31, 2019 | 93.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
93.24M
Minimum
Dec 2019
545.64M
Maximum
Mar 2021
444.38M
Average
487.93M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Candel Therapeutics Inc | 41.20M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.36M |
| Shareholders Equity (Quarterly) | 396.90M |
| Current Ratio | 25.00 |